Glaucoma is the second leading cause for blindness globally, and according to the Glaucoma Research Foundation, most never see it coming. Around 50% of the people that have glaucoma don’t know they have it. That means over 30 million people worldwide don’t know they have a disease that may cause them to go blind. Interestingly, blindness only came after cancer and heart disease as people’s major fear.
Glaucoma can often occur without any symptoms, and only 20% of people knew that it was related to elevated pressure within the eye. While these are some scary facts, cannabinoids may be an effective treatment according to this study. The abstract from this study states that:
“Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.”
Remembering that glaucoma is caused by an increased pressure within the eye, the fact that cannabinoids effectively lowered the intraocular pressure is very encouraging.
Another study tested over thirty different cannabinoids and their ability to reduce intraocular pressure. All compounds were given intravenously, and a few were given topically. It also concluded that cannabinoids were active in reducing intraocular pressure, and nearly all of them had some measurable activity.
Each person has an endocannabinoid system, which is fueled by a variety of cannabinoids and terpenes. Because our products have these cannabinoids and terpenes, they are known to be full spectrum products. These full spectrum products help provide an entourage effect. That’s Natural has been in business for over 10 years and believes in providing the most pure, potent, and trusted products possible. We even provide 100% traceability of where our hemp comes from. For more questions regarding our CBD products, please visit our Questions and Answers page.